Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma

Isabelle Audo, Soesiawati R. Darjatmoko, Cassandra L. Schlamp, Janice M. Lokken, Mary J. Lindstrom, Daniel Albert, Robert W. Nickells

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

PURPOSE. To study the antineoplastic effect of vitamin D analogues in a xenograft model of human retinoblastoma. METHODS. Athymic mice were injected subcutaneously with Y79 cells and treated 5 days a week with either mineral oil (control group) or the vitamin D analogues calcitriol of 1,25-dihydroxy-16-ene-23-yne vitamin D3 (16,23-D3). BrdU was injected 1 hour before death. Animals were killed after 1, 2, 3, or 5 weeks. Paraffin-embedded sections of the tumors were studied for cell proliferation by monitoring for BrdU incorporation and cell death by terminal transferase dUTP-nick end labeling (TUNEL), 3′-overhang ligation, and histology. Sections of the tumors were immunostained for p53 and p21. RESULTS. There was no significant difference in incorporation of BrdU among the three groups, suggesting that cell proliferation is unaffected by vitamin D analogues. TUNEL was increased in tumors treated with vitamin D analogues compared with the control group. This increase was statistically significant for calcitriol in the time frame examined, but not statistically significant for 16,23-D 3. Alternatively, the ratio of proliferation to cell death was significantly different for both calcitriol and 16,23-D3 compared with control tumors after 3 weeks of treatment. Dying cells contained DNA strand breaks with overhanging nucleotides and nuclear changes characteristic of apoptosis. There was an increase in staining for p53 and p21 in areas associated with cell death in specimens treated with vitamin D analogues. CONCLUSIONS. Vitamin D analogues appear to attenuate retinoblastoma tumor growth in athymic mice by increasing apoptosis. Cell death is associated with the upregulation of both p53 and p21.

Original languageEnglish (US)
Pages (from-to)4192-4199
Number of pages8
JournalInvestigative Ophthalmology and Visual Science
Volume44
Issue number10
DOIs
StatePublished - Oct 1 2003
Externally publishedYes

Fingerprint

Retinoblastoma
Heterografts
Vitamin D
Apoptosis
Calcitriol
Cell Death
Bromodeoxyuridine
Neoplasms
Transferases
Nude Mice
Cell Proliferation
Mineral Oil
Control Groups
DNA Breaks
Antineoplastic Agents
Paraffin
Ligation
Histology
Up-Regulation
Nucleotides

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. / Audo, Isabelle; Darjatmoko, Soesiawati R.; Schlamp, Cassandra L.; Lokken, Janice M.; Lindstrom, Mary J.; Albert, Daniel; Nickells, Robert W.

In: Investigative Ophthalmology and Visual Science, Vol. 44, No. 10, 01.10.2003, p. 4192-4199.

Research output: Contribution to journalArticle

Audo, Isabelle ; Darjatmoko, Soesiawati R. ; Schlamp, Cassandra L. ; Lokken, Janice M. ; Lindstrom, Mary J. ; Albert, Daniel ; Nickells, Robert W. / Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. In: Investigative Ophthalmology and Visual Science. 2003 ; Vol. 44, No. 10. pp. 4192-4199.
@article{10f6288d918e41438ccdd5239aa34f60,
title = "Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma",
abstract = "PURPOSE. To study the antineoplastic effect of vitamin D analogues in a xenograft model of human retinoblastoma. METHODS. Athymic mice were injected subcutaneously with Y79 cells and treated 5 days a week with either mineral oil (control group) or the vitamin D analogues calcitriol of 1,25-dihydroxy-16-ene-23-yne vitamin D3 (16,23-D3). BrdU was injected 1 hour before death. Animals were killed after 1, 2, 3, or 5 weeks. Paraffin-embedded sections of the tumors were studied for cell proliferation by monitoring for BrdU incorporation and cell death by terminal transferase dUTP-nick end labeling (TUNEL), 3′-overhang ligation, and histology. Sections of the tumors were immunostained for p53 and p21. RESULTS. There was no significant difference in incorporation of BrdU among the three groups, suggesting that cell proliferation is unaffected by vitamin D analogues. TUNEL was increased in tumors treated with vitamin D analogues compared with the control group. This increase was statistically significant for calcitriol in the time frame examined, but not statistically significant for 16,23-D 3. Alternatively, the ratio of proliferation to cell death was significantly different for both calcitriol and 16,23-D3 compared with control tumors after 3 weeks of treatment. Dying cells contained DNA strand breaks with overhanging nucleotides and nuclear changes characteristic of apoptosis. There was an increase in staining for p53 and p21 in areas associated with cell death in specimens treated with vitamin D analogues. CONCLUSIONS. Vitamin D analogues appear to attenuate retinoblastoma tumor growth in athymic mice by increasing apoptosis. Cell death is associated with the upregulation of both p53 and p21.",
author = "Isabelle Audo and Darjatmoko, {Soesiawati R.} and Schlamp, {Cassandra L.} and Lokken, {Janice M.} and Lindstrom, {Mary J.} and Daniel Albert and Nickells, {Robert W.}",
year = "2003",
month = "10",
day = "1",
doi = "10.1167/iovs.02-1198",
language = "English (US)",
volume = "44",
pages = "4192--4199",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "10",

}

TY - JOUR

T1 - Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma

AU - Audo, Isabelle

AU - Darjatmoko, Soesiawati R.

AU - Schlamp, Cassandra L.

AU - Lokken, Janice M.

AU - Lindstrom, Mary J.

AU - Albert, Daniel

AU - Nickells, Robert W.

PY - 2003/10/1

Y1 - 2003/10/1

N2 - PURPOSE. To study the antineoplastic effect of vitamin D analogues in a xenograft model of human retinoblastoma. METHODS. Athymic mice were injected subcutaneously with Y79 cells and treated 5 days a week with either mineral oil (control group) or the vitamin D analogues calcitriol of 1,25-dihydroxy-16-ene-23-yne vitamin D3 (16,23-D3). BrdU was injected 1 hour before death. Animals were killed after 1, 2, 3, or 5 weeks. Paraffin-embedded sections of the tumors were studied for cell proliferation by monitoring for BrdU incorporation and cell death by terminal transferase dUTP-nick end labeling (TUNEL), 3′-overhang ligation, and histology. Sections of the tumors were immunostained for p53 and p21. RESULTS. There was no significant difference in incorporation of BrdU among the three groups, suggesting that cell proliferation is unaffected by vitamin D analogues. TUNEL was increased in tumors treated with vitamin D analogues compared with the control group. This increase was statistically significant for calcitriol in the time frame examined, but not statistically significant for 16,23-D 3. Alternatively, the ratio of proliferation to cell death was significantly different for both calcitriol and 16,23-D3 compared with control tumors after 3 weeks of treatment. Dying cells contained DNA strand breaks with overhanging nucleotides and nuclear changes characteristic of apoptosis. There was an increase in staining for p53 and p21 in areas associated with cell death in specimens treated with vitamin D analogues. CONCLUSIONS. Vitamin D analogues appear to attenuate retinoblastoma tumor growth in athymic mice by increasing apoptosis. Cell death is associated with the upregulation of both p53 and p21.

AB - PURPOSE. To study the antineoplastic effect of vitamin D analogues in a xenograft model of human retinoblastoma. METHODS. Athymic mice were injected subcutaneously with Y79 cells and treated 5 days a week with either mineral oil (control group) or the vitamin D analogues calcitriol of 1,25-dihydroxy-16-ene-23-yne vitamin D3 (16,23-D3). BrdU was injected 1 hour before death. Animals were killed after 1, 2, 3, or 5 weeks. Paraffin-embedded sections of the tumors were studied for cell proliferation by monitoring for BrdU incorporation and cell death by terminal transferase dUTP-nick end labeling (TUNEL), 3′-overhang ligation, and histology. Sections of the tumors were immunostained for p53 and p21. RESULTS. There was no significant difference in incorporation of BrdU among the three groups, suggesting that cell proliferation is unaffected by vitamin D analogues. TUNEL was increased in tumors treated with vitamin D analogues compared with the control group. This increase was statistically significant for calcitriol in the time frame examined, but not statistically significant for 16,23-D 3. Alternatively, the ratio of proliferation to cell death was significantly different for both calcitriol and 16,23-D3 compared with control tumors after 3 weeks of treatment. Dying cells contained DNA strand breaks with overhanging nucleotides and nuclear changes characteristic of apoptosis. There was an increase in staining for p53 and p21 in areas associated with cell death in specimens treated with vitamin D analogues. CONCLUSIONS. Vitamin D analogues appear to attenuate retinoblastoma tumor growth in athymic mice by increasing apoptosis. Cell death is associated with the upregulation of both p53 and p21.

UR - http://www.scopus.com/inward/record.url?scp=0141653774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141653774&partnerID=8YFLogxK

U2 - 10.1167/iovs.02-1198

DO - 10.1167/iovs.02-1198

M3 - Article

C2 - 14507860

AN - SCOPUS:0141653774

VL - 44

SP - 4192

EP - 4199

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 10

ER -